Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
---|
05/28/2003 | EP1100576A4 Synergism of photodynamic and electropermeation effects on cell vitality as a novel cytotoxic agent |
05/28/2003 | CN1420795A Apparatus and method for microporation of biological membranes using thin film tissue interface devices |
05/28/2003 | CN1420788A Improved treatment of neovascularization |
05/27/2003 | US6569846 Photodynamic therapy and diagnosis and in vitro photodynamic killing of viruses and microorganisms |
05/27/2003 | US6569654 Electroactive materials for stimulation of biological activity of stem cells |
05/27/2003 | CA2131168C Decontaminating blood components |
05/22/2003 | WO2002083686A3 Processes for large scale production of tetrapyrroles |
05/21/2003 | EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders |
05/21/2003 | EP1311261A1 Medicaments for chemotherapeutic treatment of disease |
05/21/2003 | EP1192450A4 High energy phototherapeutic agents |
05/21/2003 | EP1146912A4 Method for improved radiation therapy |
05/21/2003 | EP1005369B1 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy |
05/21/2003 | CN1419452A Synergistic methods and compositions for treating cancer |
05/20/2003 | US6566517 Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy |
05/20/2003 | US6566070 Detecting preferential protein biosynthesis; label nucleotide sequences, mix with translation system, incubate, detct signal from protein |
05/20/2003 | US6566046 Platelet storage media mixture of sodium chloride, sodium citrate, sodium acetate, sodium phosphate ans psoralen |
05/20/2003 | US6565887 Magnetic heating efficiency, alternating frequency; antitumor, anticarcinogenic agents |
05/15/2003 | WO2003040346A2 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
05/15/2003 | WO2003040175A1 Conjugate for treating by boron neutron capture (bnc) radiation-resistant tumours |
05/15/2003 | WO2003039597A1 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment |
05/15/2003 | WO2003039596A1 Photodynamic therapy for the treatment of hair loss |
05/15/2003 | WO2003039478A2 Method and apparatus for the stimulation of hair growth |
05/15/2003 | WO2003039452A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
05/15/2003 | WO2002062384A3 Reduced fluence rate pdt |
05/15/2003 | WO2002058730A3 Compositions for treatment of ocular neovascularization |
05/15/2003 | WO2002040533A1 Radiosensitivity enhancers in radiotherapy for cancer and nucleic acids and proteins enhancing radiosensitivity |
05/15/2003 | US20030093092 Optically-absorbing nanoparticles for enhanced tissue repair |
05/15/2003 | US20030092982 Microporation of tissue for delivery of bioactive agents |
05/15/2003 | US20030092667 Delivery of therapeutic compositions using ultrasound |
05/15/2003 | US20030091602 Crosslinked polymers; photopolymerization |
05/15/2003 | CA2466880A1 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
05/15/2003 | CA2466425A1 Photodynamic therapy for the treatment of hair loss |
05/15/2003 | CA2465945A1 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
05/15/2003 | CA2429147A1 Radiosensitivity enhancers, radiosensitivity-enhancing nucleic acids and proteins in cancer radiotherapy |
05/14/2003 | EP1310460A2 Device and process for liquid treatment |
05/14/2003 | EP1309330A1 Photosensitizers with ligand targeting properties for tumor therapy |
05/14/2003 | EP1309328A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
05/14/2003 | EP1309283A2 Accurate optical treatment of an eye's fundus |
05/14/2003 | CN1416900A Polar medicine |
05/13/2003 | US6562316 Drug delivery system with two-step targeting |
05/13/2003 | CA2127114C A composition for the biological stimulation and correction of the phenotype of an organism and a method for treating the same |
05/08/2003 | WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents |
05/08/2003 | WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
05/08/2003 | WO2003037902A1 Separation of regioisomers of metal phthalocyanines |
05/08/2003 | WO2002039953A9 Texaphyrin coordination compounds and uses thereof |
05/08/2003 | WO2002024226A9 Photosensitisers |
05/08/2003 | WO2001082899A9 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
05/08/2003 | US20030088176 Non-invasive methods for surgery in the vasculature |
05/08/2003 | US20030088092 Water-soluble porphyrin derivatives and methods of their preparation |
05/08/2003 | US20030087947 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photodynamic therapy |
05/08/2003 | US20030087889 Photodynamic therapy of occult age-related macular degeneration |
05/08/2003 | CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
05/08/2003 | CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
05/07/2003 | EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins |
05/07/2003 | EP1307241A1 Photodynamic treatment and uv-b irradiation of a thrombocyte suspension |
05/07/2003 | EP1307227A2 Pharmaceutical compositions |
05/07/2003 | EP1307226A2 Vitronectin receptor antagonist pharmaceuticals |
05/07/2003 | EP1263447A4 Optically-active nanoparticles for use in therapeutic and diagnostic methods |
05/06/2003 | US6559183 Nano-emulsion of 5-aminolevulinic acid |
05/06/2003 | US6558698 Microencapsulated bioactive agents and method of making |
05/06/2003 | US6558653 That uses a dye composition and laser energy |
05/06/2003 | US6558650 Enhancement of cellular gallium uptake |
05/02/2003 | EP1306380A1 Novel expanded porphyrins and process for the synthesis thereof |
05/02/2003 | EP1305317A1 Dihydroporphyrin derivatives and their uses |
05/02/2003 | EP1094839B1 Farnesyl protein transferase inhibitors with (in vivo) radiosensitizing properties |
05/01/2003 | WO2003035108A1 Immunopotentiators in thermotherapy for cancer |
05/01/2003 | WO2003035104A2 Compositions and methods for selected tumor treatment |
05/01/2003 | WO2003034975A2 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
05/01/2003 | WO2002096365A3 Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy |
05/01/2003 | WO2002067850A9 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging |
05/01/2003 | US20030083649 Method for reducing or preventing PDT related inflammation |
05/01/2003 | US20030083494 Porphyrins containing multiple carborane cages which selectively accumulate in neoplastic tissue within the irradiation volume; anticancer agents |
05/01/2003 | US20030083324 Photosensitizing ointment |
05/01/2003 | US20030083261 Anticancer agents |
05/01/2003 | US20030082183 Methods and compositions for treatment of ocular neovascularization and neural injury |
05/01/2003 | US20030082105 Selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions |
05/01/2003 | US20030082101 Photodynamic or sonodynamic agents are subjected to light waves or sound waves in the presence of a metal, a reductant, or a chelate |
04/29/2003 | US6555663 Prodrugs for selective drug delivery |
04/29/2003 | US6555527 Hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from Panax ginseng |
04/29/2003 | US6554853 Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue |
04/24/2003 | WO2003033022A1 Use of oxaziridine derivatives and precursors in the treatment of dermatoses |
04/24/2003 | WO2003032984A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
04/24/2003 | WO2003032902A2 Tumor targeted photodiagnostic-phototherapeutic agents |
04/24/2003 | WO2003032901A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
04/24/2003 | WO2003032900A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
04/24/2003 | WO2003011265A3 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds |
04/24/2003 | US20030078499 Microporation of tissue for delivery of bioactive agents |
04/24/2003 | US20030078227 Site-directed transfection with ultrasound and cavitation nuclei |
04/24/2003 | US20030077248 Treating cancer with a culture product from a non-naturally occurring antigen-presenting cell; polyclonal antibodies expression |
04/24/2003 | CA2463994A1 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
04/24/2003 | CA2463911A1 Tumor targeted photodiagnostic-phototherapeutic agents |
04/24/2003 | CA2463906A1 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
04/23/2003 | EP1304120A1 Use of oxaziridine derivatives and precursors for the treatment of dermatoses |
04/22/2003 | US6553254 Administering ribose to energize cells being treated |
04/22/2003 | US6552005 Treating with the adenovirus encoding cytosine deaminase gene and uracil phosphoribosyltranserase gene; administering 5-fluorocytosine; therapy with radiation |
04/22/2003 | US6551618 Compositions and methods for delivery of agents for neuronal regeneration and survival |
04/22/2003 | US6551576 Container with multi-phase composition for use in diagnostic and therapeutic applications |
04/22/2003 | US6551232 Dosimetry for californium-252(252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof |
04/17/2003 | WO2003002156A3 Contrast agents comprising metal particles encapsulated in microspheres for use in medical diagnostic imaging and therapy |
04/17/2003 | WO2002032415A3 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells |